Tech Company Inital Public Offerings
Cara Therapeutics IPO
Cara Therapeutics was acquired by . The company's stock were listed on 1/31/2014.
Transaction Overview
Company Name
Announced On
1/31/2014
Transaction Type
IPO
Amount
$55,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4 Stamford Plz. 107 Elm St. 9th Floor
Stamford, CT 06902
USA
Stamford, CT 06902
USA
Phone
Website
Email Address
Overview
Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Derek Chalmers
Chief Financial Officer
Mani Mohindru
Chief Scientific Officer
Michael Lewis
VP - General Counsel
Scott Terrillion
VP - Operations
Eric Vandal
VP - R & D
Frédérique Menzaghi
Browse more venture capital transactions:
Prev: 1/31/2014: Surface Medical venture capital transaction
Next: 1/31/2014: XTuit Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs